This proof-of-principle study demonstrates improved CBF-CVR metrics using hypercapnia and hyperoxia, suggesting enhanced vascular function assessment.
Motivation: Cerebrovascular reactivity (CVR) is an important biomarker of brain's vascular function.. BOLD-based CVR mapping techniques are susceptible to multiple BOLD confounding factors. Goal(s): To develop a normalized CVR mapping approach using BOLD MRI with both hypercapnia and hyperoxia challenges and obtain CBF-CVR, which is independent of BOLD confounding factors while maintaining its superior sensitivity. Approach: A proof-of-principle study was first performed in 7 healthy subjects, followed by a test-retest reproducibility study in 11 subjects. Results: CBF-CVR obtained from the normalized CVR approach showed smaller inter-voxel coefficient of variance (CoV) and gray matter/white matter ratio than BOLD-CVR, and also reduced inter-subject variations. Impact: The normalized CVR approach, using hypercapnia and hyperoxia challenges with BOLD acquisition to obtain CBF-CVR, can provide a more direct index of the microvascular function and would be practical and promising in clinical applications of cerebrovascular diseases.
No takes yet. Share an insight, caveat, or question.
Karimigharighi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: